Wolff Wiese Magana’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Wolff Wiese Magana's BMY Position: Q2 2026 in Review
Wolff Wiese Magana increased its Bristol-Myers Squibb (BMY) stake by 0.15% in Q2 2026, buying an estimated $57 and bringing the position to 655 shares worth $37.7K. The position accounts for 0.02% of the portfolio, ranked #270.
Wolff Wiese Magana first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.93M in Q1 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wolff Wiese Magana held 655 shares of Bristol-Myers Squibb worth $37.7K as of Q2 2026.
- Wolff Wiese Magana bought 1 Bristol-Myers Squibb share in Q2 2026, an estimated $57.
- Bristol-Myers Squibb made up 0.02% of Wolff Wiese Magana's portfolio in Q2 2026, its #270 holding.
- Wolff Wiese Magana first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- Wolff Wiese Magana's Bristol-Myers Squibb position peaked at $2.93M in Q1 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.